WaveMan
WaveMan · Company
FLSC · Frazier Life Sciences Acquisition Corp. Ii
> Search tickers & screens ⌘K
LIVE
← All companies

FLSC Frazier Life Sciences Acquisition Corp. II (FLSC) Insider Trading, Ownership & Congress Trades

CIK 0002153598
Activist 13DC-suite buying · 1
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
0
13F, latest reported quarter

What the filings say about FLSC

Insiders, 180 days
+$3.0M net bought
1 buyer
Activist stakes (13D), 180 days
1 filing
Largest: 20.5% of the class

Frazier Life Sciences Acquisition Corp. II insider trades (Form 4)

Form 4 buys and sells (codes P and S). Grants, option exercises and conversions excluded.

Over the last 180 days, Frazier Life Sciences Acquisition Corp. II insiders bought a net $3.0M of stock across 1 Form 4 purchases and sales, with 1 insider buying. Source: SEC Form 4 filings, as of 2026-10-28.

Insider
Filed
Shares
Value
Since filing
Chief Executive Officer
BUY
2026-10-15 SEC
300,000
$3.0M
n/a
Context
  • First Form 4 purchase or sale (code P or S) here by this insider on our record.
  • The trade is 100.0% of the 300,000 shares held after it.
  • No other insider bought within 30 days.
Insider activity: Chief Executive Officer Cha Albert bought about $3.0M of FLSC on Oct 15, 2026, the largest insider purchase at the company on our record.
1 transaction on record · a thin record, read with care
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Showing the latest few. to use the screener and CSV export. We store only your email; there is no password.
Seven facts, ranked against the sector · Rank is not a forecast
Insiders
net +$3.0M over 180 days
+$3.0M over 90 days · +$3.0M of it by a 10%+ holder
more than 65% of its sector
Congress
no House purchase disclosed in the last 12 months
Funds
under five funds report holding it
Revenue
no revenue reported in any filing
Margin
no margin: no revenue reported
Buybacks
no share repurchases reported
Short interest
1.0 days to cover · settled 2026-10-15
The situation: each line is one rule over one dataset
Frazier Life Sciences Holdings II LLC disclosed a 5%+ stake (20.5%) in the last six months.
What changed in the last 30 days
Oct 21Frazier Life Sciences Holdings II LLC filed a 13D for 20.5%
Oct 21Albert Cha filed a 13D for 20.5%
Oct 21Frazier Life Sciences Public Fund, L.P. filed a 13D for 20.5%
Oct 21FHMLSP, L.P. filed a 13D for 20.5%
Oct 21FHMLSP, L.L.C. filed a 13D for 20.5%

Watch FLSC

A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.

Who owns FLSC: institutional holders (13F)

13F holdings, latest reported quarter
SEC 13F
No reported 13F holders

No fund above the reporting threshold listed this stock last quarter. That is a fact, not missing data.

Congress trades in FLSC

No Congress trades reported
No House member has disclosed a trade in this stock. See what Congress is buying.

Activist and 5% holders (13D/13G)

13D: intends to influence · 13G: passive
Frazier Life Sciences Holdings II LLC
Activist 13D · 2026-10-21
20.5%
Albert Cha
Activist 13D · 2026-10-21
20.5%
Frazier Life Sciences Public Fund, L.P.
Activist 13D · 2026-10-21
20.5%
FHMLSP, L.P.
Activist 13D · 2026-10-21
20.5%
FHMLSP, L.L.C.
Activist 13D · 2026-10-21
20.5%

FLSC planned insider sales (Form 144)

No planned-sale notices
No insider has filed to sell. Watch this after a run-up.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
An activist crossed the 5% line with declared intent.
The record shows a net $3.0M bought by insiders over 180 days. Each figure is a federal filing, dated the day it went public.

FLSC Stock Sonar score 1/7 axes

Find similar shapesCompare
Insider conviction
75
Inputs
  • Net Form 4 buying (codes P and S), 180d$3.0M · 95 pct, universe of 3,403
  • Insider buyers, 180d1 · 56 pct, universe of 3,445
6 not measured: Profitability, Financial health, Growth, Institutional and government, Risk and compliance, US patents
  • Profitability needs 2 of 4 inputs, 0 present: not filed
  • Financial health needs 1 of 2 inputs, 0 present: not filed
  • Growth needs 1 of 2 inputs, 0 present: no backlog line filed, or no year-earlier backlog; no revenue for this year and the year before
  • Institutional and government needs 1 of 4 inputs, 0 present: fewer than five funds report holding it; no Congress trades in 365 days; no federal contracts in 180 days; no lobbying filings in the last four quarters
  • Risk and compliance needs 1 of 4 inputs, 0 present: needs two 10-Ks with a Risk Factors section (not 20-F filers or stubs); no short interest or no free float on file; revenue under $50M or not filed, so a count cannot be scaled to size
  • US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet

1 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored

FLSC filings, in plain words

Are Frazier Life Sciences Acquisition Corp. II insiders buying or selling FLSC?

In the 180 days to 2026-10-28, Frazier Life Sciences Acquisition Corp. II insiders were net buyers, a net $3.0M across purchases and sales reported on Form 4, by 1 buyer.

Read the full summary

In the 180 days to 2026-10-28, Frazier Life Sciences Acquisition Corp. II insiders were net buyers of FLSC, a net $3.0M across purchases and sales reported on Form 4 by 1 buyer. Most of that figure, $3.0M, came from a holder of 10% or more rather than an officer or director. 1 activist Schedule 13D filing in the last 180 days declared an intent to influence the company, the largest for 20.5% of the class. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.

Explore insider trading and ownership data

Every company we track, ranked by each kind of filing